聚蛋白多糖酶(aggrecanase)是新发现的降解软骨组织重要成分聚蛋白多糖(aggrecan)的金属蛋白酶,是治疗关节炎的新靶点.Aggrecanase的发现使得关节炎的治疗有望取得新的突破,为能从根本上治疗和预防关节炎提供了基础.综述了aggrecanase从克隆到对其性质的研究,阐明以该酶为靶点寻找抑制剂是治疗与预防关节炎的一条可能的途径.
Aggrecan degradation is an important factor in the erosion of articular cartilage in arthritis. Aggrecanase is a newly cloned enzyme which degrades the core protein of aggrecan between the Glu373 and Ala374, a site different from the matrix metalloproteinases cleavage site, Asn341~Phe342. The discovery of aggrecanase and searching for its inhibitors will accelerate the development of therapeutic agents for arthritis.
李静雅,叶其壮.治疗关节炎症的新靶点——聚蛋白多糖酶Aggrecanase的研究进展[J].生物化学与生物物理进展,2001,28(5):654-657
复制生物化学与生物物理进展 ® 2025 版权所有 ICP:京ICP备05023138号-1 京公网安备 11010502031771号